Verona Pharma Plc ADR
(VRNA)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2017 | 06-2017 | 12-2016 | 06-2016 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | 41,100 | 80,077 | 53,921 | N/A |
| Marketable Securities | 70,782 | 40,870 | 0 | N/A |
| Receivables | 4,017 | 3,594 | 1,447 | N/A |
| Other current assets | 0 | 0 | 4,009 | 0 |
| TOTAL | $121,026 | $127,654 | $59,377 | $N/A |
| Non-Current Assets | ||||
| PPE Net | 17 | 16 | N/A | N/A |
| Intangibles | 3,201 | 3,073 | 0 | 0 |
| Other Non-Current Assets | 0 | 0 | 3,141 | 0 |
| TOTAL | $3,218 | $3,089 | $3,141 | $N/A |
| Total Assets | $124,244 | $130,743 | $62,537 | $N/A |
| Liabilities | ||||
| Current Liabilities | ||||
| Accounts payable and accrued liabilities | 6,221 | 6,789 | 3,827 | 0 |
| Other current liabilities | 5,233 | 3,593 | 10,738 | N/A |
| TOTAL | $11,557 | $10,507 | $14,735 | $N/A |
| Non-Current Liabilities | ||||
| Other Non-Current Liabilities | 1,116 | 1,069 | 1,087 | 0 |
| TOTAL | $1,116 | $1,069 | $1,087 | $N/A |
| Total Liabilities | $12,672 | $11,576 | $15,822 | $N/A |
| Shareholders' Equity | ||||
| Common Shares | 6,874 | 6,707 | 3,480 | N/A |
| Retained earnings | -56,274 | -43,298 | -38,935 | N/A |
| Other shareholders' equity | 5,359 | 3,926 | 2,849 | 0 |
| TOTAL | $111,572 | $119,167 | $46,715 | $N/A |
| Total Liabilities And Equity | $124,244 | $130,743 | $62,537 | $0 |